1. Home
  2. MKZR vs CLDI Comparison

MKZR vs CLDI Comparison

Compare MKZR & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MKZR
  • CLDI
  • Stock Information
  • Founded
  • MKZR 2012
  • CLDI 2014
  • Country
  • MKZR United States
  • CLDI United States
  • Employees
  • MKZR N/A
  • CLDI N/A
  • Industry
  • MKZR
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MKZR
  • CLDI Health Care
  • Exchange
  • MKZR Nasdaq
  • CLDI Nasdaq
  • Market Cap
  • MKZR 11.4M
  • CLDI 10.2M
  • IPO Year
  • MKZR N/A
  • CLDI N/A
  • Fundamental
  • Price
  • MKZR $0.63
  • CLDI $0.23
  • Analyst Decision
  • MKZR
  • CLDI Strong Buy
  • Analyst Count
  • MKZR 0
  • CLDI 1
  • Target Price
  • MKZR N/A
  • CLDI $10.00
  • AVG Volume (30 Days)
  • MKZR 59.5K
  • CLDI 1.8M
  • Earning Date
  • MKZR 08-11-2025
  • CLDI 08-12-2025
  • Dividend Yield
  • MKZR 52.58%
  • CLDI N/A
  • EPS Growth
  • MKZR N/A
  • CLDI N/A
  • EPS
  • MKZR N/A
  • CLDI N/A
  • Revenue
  • MKZR $23,037,348.00
  • CLDI N/A
  • Revenue This Year
  • MKZR N/A
  • CLDI N/A
  • Revenue Next Year
  • MKZR N/A
  • CLDI N/A
  • P/E Ratio
  • MKZR N/A
  • CLDI N/A
  • Revenue Growth
  • MKZR 52.64
  • CLDI N/A
  • 52 Week Low
  • MKZR $0.60
  • CLDI $0.20
  • 52 Week High
  • MKZR $5.50
  • CLDI $3.89
  • Technical
  • Relative Strength Index (RSI)
  • MKZR N/A
  • CLDI 21.13
  • Support Level
  • MKZR N/A
  • CLDI $0.31
  • Resistance Level
  • MKZR N/A
  • CLDI $0.33
  • Average True Range (ATR)
  • MKZR 0.00
  • CLDI 0.04
  • MACD
  • MKZR 0.00
  • CLDI -0.01
  • Stochastic Oscillator
  • MKZR 0.00
  • CLDI 14.83

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

Share on Social Networks: